Quality Assurance & Industrial Manufacturing Standards

At Renduan Biomedical Technology Co., Ltd. (“Renduan Biomed”), quality is not merely a final inspection metric—it is engineered into every stage of our hybridoma cell banking, recombinant protein expression, chromatographic purification, and functional validation processes.

As a dedicated source manufacturer supplying critical diagnostic antibodies and authentic antigens to global In Vitro Diagnostic (IVD) test kit developers, we adhere to rigorous industrial standards designed to ensure flawless lot-to-lot reproducibility, ultra-high analytical sensitivity, and commercial supply security.

1. Comprehensive Analytical Release Testing Battery

Every production lot dispatched from our Suzhou manufacturing facility must undergo and pass an exhaustive battery of physicochemical and functional testing. Batch-specific data are documented in a formal Certificate of Analysis (CoA) provided with each delivery:

  • Purity & Integrity (SDS-PAGE):
    Purity ≥ 95% confirmed under both reducing and non-reducing SDS-PAGE conditions to verify complete IgG assembly and absence of degraded fragments.
  • Monomer Fractionation (Analytical SEC-HPLC):
    Size-Exclusion Chromatography is routinely performed on liquid monoclonal antibodies to quantify monomer fractions (typically > 95%), strictly screening out soluble aggregates that could cause background elevation in immunoassays.
  • Protein Quantification & Identity:
    Precise concentration measurement verified via spectrophotometry (BCA Assay & Absorbance at A280 with extinction coefficient calibration).
  • Buffer & Preservative Matrix Control:
    100% Azide-Free and Carrier-Free (BSA-Free) formulations standard, 0.22 μm sterile-filtered under certified cleanroom conditions (pH 7.4 ± 0.2, conductivity verified).

2. Functional Assay Validation

Biochemical purity does not guarantee clinical diagnostic utility. Renduan Biomed bridges this gap by validating our matched antibody pairs on real clinical diagnostic platforms:

  • Matched-Pair Affinity & Calibration Verification:
    Every antibody pair is functionally screened on automated Magnetic Particle Chemiluminescence Immunoassay (CLIA) and digital single-molecule (Simoa-equivalent) detection systems.
  • Sensitivity & Matrix Recovery:
    Demonstrated sub-picogram limits of detection (LLOD) and spike-and-recovery rates of 90%–110% in authentic human EDTA plasma, serum, and cerebrospinal fluid (CSF) matrices.
  • Cross-Reactivity Screening:
    Specificity cross-reactivity profiling against related isoforms (e.g., verifying zero binding of p-Tau217 to non-phosphorylated Tau, p-Tau181, or p-Tau231).

3. Lot-to-Lot Consistency & Bridge Testing

To protect our commercial partners against assay recalibration and clinical trial disruptions, we implement strict batch-to-batch consistency controls:

  • Bridging Validation Protocol:
    Prior to releasing a new industrial bulk lot (multi-gram scale), the new lot is benchmarked directly against the established reference lot using standard calibration curves.
  • Tolerance Limits:
    Functional binding signals, background noise ratios, and standard curve slope variations must fall within CV < 5%.
  • Master Cell Banking (MCB):
    Proprietary hybridoma clones and recombinant expression host cells are cryopreserved in liquid nitrogen master and working cell banks under 24/7 temperature monitoring to ensure genetic stability across decades.

4. Change Control & Notification Commitment

We recognize that in vitro diagnostic manufacturing requires regulatory stability:

  • Pre-Notification Commitment:
    In the event of any planned modifications to our upstream cell cultivation, raw material suppliers, formulation matrix, or downstream chromatography protocols, Renduan Biomed provides OEM and long-term supply contract partners with a minimum 90-day advance written notice.
  • Bridging Sample Supply:
    Customers are provided with bridging evaluation samples prior to any commercial batch transition to enable in-house validation.

5. Cold-Chain Logistics & Global Distribution Security

Biological reagents are intrinsically temperature-sensitive. Renduan Biomed secures product integrity throughout international transit:

  • Packaging Qualification:
    Shipped in validated high-density insulated thermal shippers with dry ice or phase-change blue ice packs engineered to maintain 2°C–8°C or <-20°C for up to 96 hours.
  • Real-Time Monitoring:
    Temperature-indicator monitors included upon request for international bulk consignments.
  • Traceable Expedited Courier:
    Direct dispatch via FedEx / DHL Priority Cold-Chain with complete customs declaration and clearance dossiers.

6. Supplier Qualification & Audit Inquiries

We welcome technical audit questionnaires and quality compliance reviews from global IVD reagent manufacturers. To request our comprehensive Quality Dossier, Facility Audit Form, or BSE/TSE-Free Certificates:

  • Email: gujia925@gmail.com
  • Facility: Renduan Biomedical Technology Co., Ltd., Floor 6, Building 1, No. 2358 Chang’an Road, Wujiang District, Suzhou, China